These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3798418)
21. Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate. Griffith MJ Thromb Res; 1982 Feb; 25(3):245-53. PubMed ID: 7064134 [TBL] [Abstract][Full Text] [Related]
22. The effect of protein adsorption on the anticoagulant activity of surface immobilized heparin. van Delden CJ; Engbers GH; Feijen J J Biomater Sci Polym Ed; 1996; 7(8):727-40. PubMed ID: 8639481 [TBL] [Abstract][Full Text] [Related]
23. The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin. Heuck CC; Schiele U; Horn D; Fronda D; Ritz E J Biol Chem; 1985 Apr; 260(8):4598-603. PubMed ID: 3988727 [TBL] [Abstract][Full Text] [Related]
25. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin. Speight MO; Griffith MJ Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction. Scully MF; Ellis V; Kakkar VV Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III. Baruch D; Lindhout T; Wagenvoord R; Hemker HC Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193 [TBL] [Abstract][Full Text] [Related]
28. Fabrication and characterization of heparin functionalized membrane-mimetic assemblies. Tseng PY; Rele SM; Sun XL; Chaikof EL Biomaterials; 2006 Apr; 27(12):2627-36. PubMed ID: 16368135 [TBL] [Abstract][Full Text] [Related]
29. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model. Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518 [TBL] [Abstract][Full Text] [Related]
30. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms. Carlson TH; Kolman MR; Frees A; Babcock T Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824 [TBL] [Abstract][Full Text] [Related]
31. Effect of heparin on the interaction between thrombin and hirudin. Stone SR; Hofsteenge J Eur J Biochem; 1987 Dec; 169(2):373-6. PubMed ID: 3691497 [TBL] [Abstract][Full Text] [Related]
32. Antithrombin III and heparin inactivation in thrombin involving reactions. Marciniak E Thromb Haemost; 1977 Aug; 38(2):486-93. PubMed ID: 579490 [TBL] [Abstract][Full Text] [Related]
33. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III. Smith BA; Sefton MV J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905 [TBL] [Abstract][Full Text] [Related]
34. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms. Delvos U; Meusel P; Preissner KT; Müller-Berghaus G Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084 [TBL] [Abstract][Full Text] [Related]
35. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism. Preissner KT; Delvos U; Müller-Berghaus G Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185 [TBL] [Abstract][Full Text] [Related]
36. Coagulant and noncoagulant thrombin enzymatic activity on the endothelium. Frebelius S; Nydahl S; Swedenborg J Blood Coagul Fibrinolysis; 1990 Aug; 1(3):285-92. PubMed ID: 2103313 [TBL] [Abstract][Full Text] [Related]
37. Interaction of human alpha-thrombin with artificial surfaces and reactivity of adsorbed alpha-thrombin. Chuang HY; Mohammad SF; Sharma NC; Mason RG J Biomed Mater Res; 1980 Jul; 14(4):467-76. PubMed ID: 7400198 [No Abstract] [Full Text] [Related]
38. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition. Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936 [TBL] [Abstract][Full Text] [Related]
39. Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance. van Delden CJ; Lens JP; Kooyman RP; Engbers GH; Feijen J Biomaterials; 1997 Jun; 18(12):845-52. PubMed ID: 9184748 [TBL] [Abstract][Full Text] [Related]
40. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III. Hijikata-Okunomiya A; Okamoto S; Wanaka K Thromb Res; 1990 Sep; 59(6):967-77. PubMed ID: 2264021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]